Pharma Focus Asia
KP - Sustainable Packaging Solutions

Catalent Announces Completion of First Phase of US$7.3 Million Expansion


Catalent Pharma Solutions announced the completion of the first phase of a US$7.3 million investment to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy.


The first phase of investment, which was completed in August 2018, witnessed the expansion and upgrade of the facility's integrated packaging capabilities, and the commissioning of the first of five new softgel encapsulation lines.

The second phase of the investment will add four encapsulation lines, which will bring the total number of lines to 23.

It will significantly expand production, drying, and inspection capacity for nutritional supplements and beauty softgels at the site.

It is expected that these four new lines will be fully operational by January 2019.

The investment is driven by increasing demand for nutritional and beauty products globally.

It will also enable Catalent to better serve these markets.


NameCatalent Pharma Solutions
BudgetUS$7.3 million
Parties InvolvedCatalent Pharma Solutions
ScheduleScheduled to be operational by 2019
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?